Literature DB >> 33585105

Granulomatosis With Polyangiitis: Remissions in a Thiopurine Fast Metabolizer Over 20 Years.

Ana Pedroso1,2, Lutz Beckert2.   

Abstract

A 35-year-old Maori man presented with lethargy, nasal congestion, scleritis, epistaxis, progressive shortness of breath, myalgia, and pleuritic pain. His CT scan showed bilateral pulmonary infiltrates and a corneal biopsy confirmed granulomatosis with polyangiitis (GPA).  Remission was achieved with cyclophosphamide-based regimen. Maintaining remission proved difficult because of treatment side effects or relapses on cyclophosphamide, methotrexate, or azathioprine maintenance regimes. Overall, he needed six courses of pulse cyclophosphamide / IV methylprednisolone therapy in his first 10 years of treatment. He was identified to be an azathioprine fast metabolizer producing little active metabolite at usual doses. The combination of low dose azathioprine / allopurinol achieved therapeutic level of 6-thioguanine nucleotides (TGNs) to achieve long-term remission. Low dose azathioprine / allopurinol at levels to control inflammatory bowel disease achieve long-term remission of GPA. He has been in remission for 10 years without side effects or relapses.
Copyright © 2021, Pedroso et al.

Entities:  

Keywords:  allopurinol; azathioprine; granulomatosis; polyangiitis; thiopurines

Year:  2021        PMID: 33585105      PMCID: PMC7872474          DOI: 10.7759/cureus.12616

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

1.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction.

Authors:  G G Hunder; W P Arend; D A Bloch; L H Calabrese; A S Fauci; J F Fries; R Y Leavitt; J T Lie; R W Lightfoot; A T Masi
Journal:  Arthritis Rheum       Date:  1990-08

2.  Association between 6-thioguanine nucleotides levels and clinical remission in inflammatory disease: a meta-analysis.

Authors:  Amelie Carla Moreau; Stephane Paul; Emilie Del Tedesco; Melanie Rinaudo-Gaujous; Nabila Boukhadra; Christian Genin; Laurent Peyrin-Biroulet; Xavier Roblin
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

3.  Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.

Authors:  M C Dubinsky; S Lamothe; H Y Yang; S R Targan; D Sinnett; Y Théorêt; E G Seidman
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

4.  Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.

Authors:  Loïc Guillevin; Christian Pagnoux; Alexandre Karras; Chahera Khouatra; Olivier Aumaître; Pascal Cohen; François Maurier; Olivier Decaux; Jacques Ninet; Pierre Gobert; Thomas Quémeneur; Claire Blanchard-Delaunay; Pascal Godmer; Xavier Puéchal; Pierre-Louis Carron; Pierre-Yves Hatron; Nicolas Limal; Mohamed Hamidou; Maize Ducret; Eric Daugas; Thomas Papo; Bernard Bonnotte; Alfred Mahr; Philippe Ravaud; Luc Mouthon
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

5.  Wegener's granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient.

Authors:  J L O'Donnell; V R Stevanovic; C Frampton; L K Stamp; P T Chapman
Journal:  Intern Med J       Date:  2007-04       Impact factor: 2.048

6.  Monitored high-dose azathioprine treatment reduces acute rejection episodes after renal transplantation.

Authors:  S Bergan; H E Rugstad; O Bentdal; G Sødal; A Hartmann; T Leivestad; O Stokke
Journal:  Transplantation       Date:  1998-08-15       Impact factor: 4.939

7.  Optimisation of azathioprine immunosuppression after organ transplantation by pharmacological measurements.

Authors:  S Bergan
Journal:  BioDrugs       Date:  1997-12       Impact factor: 5.807

Review 8.  Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.

Authors:  C Mukhtyar; O Flossmann; B Hellmich; P Bacon; M Cid; J W Cohen-Tervaert; W L Gross; L Guillevin; D Jayne; A Mahr; P A Merkel; H Raspe; D Scott; J Witter; H Yazici; R A Luqmani
Journal:  Ann Rheum Dis       Date:  2007-10-02       Impact factor: 19.103

Review 9.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

10.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.